Sinclair plc has released an unaudited earnings update for the six months that followed on 31 June . Sales for the period were £ 23.3 m ( $ 30.9 ) versus £ 20.1 m for the same period in 2017 equating to 6 % headline growth . The analysts estimated that performance of the group contributed £ 20.5 m , delivering an encouraging 16.5 % growth equivalent to 18 % on a constant currency basis . The new sales force in the US for Silhouette Instalift generated £ 800,000 of revenue .
Sinclair Pharma has released an unaudited trading update for the six months that ended on 30 June. Sales for the period were £23.3m ($30.9) versus £20.1m for the same period in 2017 equating to 6% headline growth. The company stated that performance of the group contributed £20.5m, delivering an encouraging 16.5% growth equivalent to 18% on a constant currency basis. The new sales force in the US for Silhouette Instalift generated £800,000 of revenue.